trametinib

Ukraine

Drugs containing this active substance

  • MEKINIST

    The drug is prescribed to adults for the treatment of unresectable or metastatic melanoma with a BRAF V600 gene mutation. It is also used for the adjuvant treatment of stage III melanoma after complete resection and for the treatment of advanced non-small cell lung cancer with a BRAF V600 mutation.

    Form: tablets, film-coated

    Active substance Dosage
    trametinib 0.5 mg

    ATC: L01EE01

    Manufacturer: GlaxoSmithKline Manufacturing S.p.A. (manufacturer of unpackaged products and quality control)

  • MEKINIST

    The drug is prescribed to adults for the treatment of unresectable or metastatic melanoma with a BRAF V600 gene mutation, as well as for the adjuvant treatment of stage III melanoma after complete resection. Additionally, it is used for the treatment of advanced non-small cell lung cancer with a BRAF V600 mutation.

    Form: tablets, film-coated

    Active substance Dosage
    trametinib 2 mg

    ATC: L01EE01

    Manufacturer: GlaxoSmithKline Manufacturing S.p.A. (manufacturer of unpackaged products and quality control)